Progressive Care, Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Progressive Care, Inc. (OTCQB: RXMD) operates as a healthcare services and technology company focused on pharmacy solutions and third-party administration in South Florida. The company, founded in 2006 and headquartered in Hallandale Beach, Florida, provides prescription pharmaceuticals, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, 340B contracted pharmacy services, third-party administration, data management, and prescription medications to long-term care facilities through subsidiaries including Pharmco, LLC, PharmcoRx pharmacies, and Smart Medical Alliance, Inc.; it targets federally qualified health centers, assisted living facilities, senior living communities, and PACE programs with specialized offerings such as medication synchronization, custom packaging, E-MAR integration, 24/7 pharmacist access, compliance management, claims optimization, and ClearMetrX data analytics. Progressive Care became a majority-owned subsidiary of NextPlat Corp (NASDAQ: NXPL) on July 1, 2023, following NextPlat's acquisition, and completed a definitive business combination merger on October 1, 2024, under which it became a wholly-owned subsidiary with Progressive Care shareholders receiving 1.4865 NextPlat shares per RXMD share and RXMD ceasing OTCQB trading; this transaction enables revenue synergies, cost reductions from eliminating redundant public company expenses, expansion of consumer offerings with NextPlat's OTC products like the Florida Sunshine vitamins brand, and unified growth in healthcare services, technology, and personal wellness markets amid reported 17% healthcare revenue increases driven by 340B contracts and prescription growth in 2024.
ATKINS NAMED A WINNER IN PROGRESSIVE GROCER'S 2025 EDITORS' PICKS AWARDS
Progressive Care Inc. Announces Results of Special Meeting of Stockholders
NextPlat Reports 474% Increase in Consolidated Q2 Revenues to $17 Million and Record 34.2% Quarterly Margins; $70 Million in 2024 Annual Revenues Expected
Progressive Care Inc. Announces Second Quarter 2024 Revenues of $13.5 Million, an Increase of 17% as Gross Margin Expands to 35%
Global Telesat Begins Sales of SpaceX's Starlink as Authorized Reseller Through Joint Venture Agreement with Pivotel Solutions Inc. (dba Pulsar)
Q2 2024 Earnings Estimate for The Progressive Co. Issued By William Blair (NYSE:PGR)
Q2 2024 Earnings Estimate for The Progressive Co. (NYSE:PGR) Issued By Roth Capital
Progressive Care Inc. Announces Record First Quarter 2024 Revenues of $14.6 Million, an Increase of 28% Over First Quarter 2023 Results
NEXTPLAT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of NextPlat Corp - NXPL
NEXTPLAT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of NextPlat Corp - NXPL
RXMD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Progressive Care Inc. Is Fair to Shareholders
NextPlat Announces Proposed Business Combination with Progressive Care Inc.
NextPlat Reports Consolidated Year-End 2023 Results with Increased Revenues of $37.8 Million, Record Annual Margins of 30% and $26.3 Million in Cash
NextPlat Expands North American Technology E-Commerce Business with Acquisition of Outfitter Satellite Inc.
Progressive Care's PharmcoRx Pharmacies Expands Medicare Advantage Over-the-Counter Benefits Acceptance Program Through New Agreement with ProHealth Connect
PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings
Progressive Care's PharmcoRx Enters into Agreement with NationsBenefits to Offer Enhanced OTC Benefits to Health Plan Members
Progressive Care Inc. Announces Record Second Quarter 2023 Results with Revenues of $11.6 Million and Gross Margins of 31%
Progressive Care Announces Shareholder Conference Call and Business Update on November 14, 2022
Progressive Care, Inc. (RXMD) CEO Alan Jay Weisberg on Q2 2022 Results - Earnings Call Transcript